Newsletter | October 10, 2024

10.10.24 -- The Peril Of Analytical Methods Transfer

SPONSOR

Your cells will no longer be in the dark!

Don’t struggle with the need to shield your bioreactor from light to monitor in-line and in real time CPPs and CQAs with Raman spectroscopy, thanks to our straylight management solution! Read how in this application note.

FOCUS ON ANALYTICS & QUALITY

The Peril Of Analytical Methods Transfer

Scale-up in all its iterations from bench to commercial readiness, tech transfer to an outsourced manufacturing partner, product acquisition, manufacturing equipment or consumables change, and even process development personnel turnover place analytical decisions made early on under a microscope. 

Standardize Flow Cytometry Data With Easy Assay Transfer Across Sites

Gain insight into how a global pharmaceutical company successfully transferred their cell therapy assays across international locations.

Safer Single-Use Materials To Enhance Advanced Therapy Manufacturing

Single-use technology suppliers must align with advanced therapy manufacturers to de-risk manufacturing processes and chemical composition requirements to maintain the safety and efficacy of new treatments.

ANALYTICS & QUALITY SOLUTIONS

Remote Cleanroom Microbial Air Sampler (Annex 1 Compliant) - Particle Measuring Systems

SPONSOR

Webinar: How to Plan for Trouble-Free Filter Validation

Join Cytiva as they discuss regulatory expectations for process-specific filter validation in drug products requiring sterile filtration. Learn best practices for conducting process-specific filter studies, essential for marketing authorization applications such as NDA and MMA. Participants will learn about timing for validation, laboratory requirements, and strategies for successful implementation across various drug types, including monoclonal antibodies and advanced therapy medicinal products. Click here to learn more.

FOCUS ON REGULATORY

Strategies To Address FDA CMC Trends For mRNA Therapies

A CMC consultant shares learnings from recent interactions with FDA regulators. The discussion primarily addresses prophylactic mRNA-LNP vaccines, though many considerations apply equally to therapeutic mRNA-LNP applications.

Top 6 Reasons To Digitize Your Data

Here are six reasons why digitizing your data is worth the time and effort needed to adjust to the vernacular and understand which steps to take first.

Imagine The Future: Enhanced Oligonucleotide Synthesis

Learn about flexible control software that has revolutionized the way method creation, evaluation, and process optimizations for scale-up are completed.

REGULATORY SOLUTIONS

Uniquely Ergonomic System Microscopes With Intelligent Automation - Danaher Life Sciences

Connect With Bioprocess Online: